Results 31 to 40 of about 53,707 (310)
, 2021 Conjugation of carbohydrate antigens with a carrier protein is a clinically proven strategy to overcome the poor immunogenicity of bacterial polysaccharide.
조상래
core +1 more source
Uptake of Pneumococcal Vaccines Among U.S. Adults After 2022 Update to Recommendations
AJPM FocusIntroduction: Updated recommendations for adult pneumococcal vaccination in the U.S. (publication date: January 27, 2022) incorporated 2 new vaccines (15- and 20-valent pneumococcal conjugate vaccines), removed 13-valent pneumococcal conjugate vaccine ...
Ahuva Averin, MPP +5 more
doaj +1 more source
Severe polyserositis induced by the 13-valent pneumococcal conjugate vaccine: a case report
Journal of Medical Case Reports, 2017 Background The United States Advisory Committee on Immunization Practices recommends administration of the 13-valent pneumococcal conjugate vaccine in series with the 23-valent pneumococcal polysaccharide vaccine for prevention of pneumonia in the ...
Pierre Tawfik +2 more
doaj +1 more source
Frontiers in Immunology, 2021 Passive immunization with specific egg yolk antibodies (immunoglobulin Y, IgY) is emerging as a promising alternative to antibiotics to control bacterial infections.
Ximin Zeng +7 more
doaj +1 more source
Expert Review of Vaccines, 2003 Conjugate vaccines in which the capsular polysaccharide of Haemophilus influenzae type b, common serotypes of Streptococcus pneumoniae and group C Neisseria meningitidis are covalently bound to a protein antigen to convert a T-cell-independent immune response into a T-cell-dependent response have proved highly effective in the prevention of invasive ...
openaire +2 more sources
Interactions of conjugate vaccines and co-administered vaccines [PDF]
Human Vaccines & Immunotherapeutics, 2015 Conjugate vaccines play an important role in the prevention of infectious diseases such as those caused by the bacteria Haemophilus influenzae (Hi) type b (Hib), Neisseria meningitidis, and Streptococcus pneumoniae. Vaccines developed against these 3 pathogens utilize 3 main carrier proteins, non-toxic mutant of diphtheria toxin (CRM197), diphtheria ...
H, Findlow, R, Borrow
openaire +2 more sources
Trends and variations in the epidemiology of meningococcal disease in Kuwait 1987–2013
Journal of Infection and Public Health, 2015 Summary: The introduction of Haemophilus influenzae type b (Hib) conjugate vaccine and conjugate pneumococcal vaccine into routine childhood vaccination in Kuwait has resulted in the emergence of Neisseria meningitidis as the leading cause of invasive ...
Entesar H. Husain +2 more
doaj +1 more source
Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study [PDF]
, 2011 We investigated the effect of the 7-valent pneumococcal conjugate vaccine (PCV7) programme in England on serotype-specific carriage and invasive disease to help understand its role in serotype replacement and predict the impact of higher valency vaccines.
Andrews, Nick +24 more
core +1 more source
Invasive pneumococcal disease in relation to vaccine type serotypes
Human Vaccines & Immunotherapeutics, 2019 Since 1983 the world has been introduced to four vaccines combating disease caused by Streptococcus pneumoniae bacteria. However, despite vaccination programs disease caused by S.
Paeton L. Wantuch, Fikri Y. Avci
doaj +1 more source
Adesão às novas vacinas conjugadas. Vacina anti-meningocócica e anti-pneumocócica.
Acta Médica Portuguesa, 2004 The new conjugate vaccines against group C meningococcal infection and pneumococcal infection were introduced in Portugal in 2001. In 2001/2002, the media published several alarming news on meningococcal disease and there was an increased demand of those
Laurinda De Queirós +3 more
doaj +1 more source